Effects of 1α,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: Differentiation-stage dependence and modulation by 17-β estradiol

Bone

Volumn 19, Issue 6, 1996, Pages 621-627

  Rao, L G ^a   Sutherland, M K ^a   Reddy, G S ^b   Siu Caldera, M L ^b   Uskokovic, M R ^c   Murray, T M ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c HOFFMANN LA ROCHE INC   (United States)

Author keywords

1 ,25 dihydroxyvitamin D3; Alkaline phosphatase; Analog; Osteocalcin; PTH stimulated adenylate cyclase; Thymidine uptake

Indexed keywords

ADENYLATE CYCLASE; ALKALINE PHOSPHATASE; COLECALCIFEROL DERIVATIVE; ESTRADIOL; OSTEOCALCIN; 1 ALPHA,24 DIHYDROXYVITAMIN D3; 1 ALPHA,24-DIHYDROXYVITAMIN D3; 9,10 SECOCHOLESTA 5,7,10(19),16 TETRAEN 23 YNE 1,3,25 TRIOL; CALCITRIOL; DIHYDROXYCOLECALCIFEROL; DRUG DERIVATIVE; PARATHYROID HORMONE; RO 23-7553; THYMIDINE;

ARTICLE; CELL DIFFERENTIATION; OSTEOBLAST; OSTEOSARCOMA CELL; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; METABOLISM; OSTEOSARCOMA;

ADENYLATE CYCLASE; ALKALINE PHOSPHATASE; CALCITRIOL; CELL DIFFERENTIATION; DIHYDROXYCHOLECALCIFEROLS; ESTRADIOL; HUMANS; OSTEOBLASTS; OSTEOCALCIN; OSTEOSARCOMA; PARATHYROID HORMONE; THYMIDINE; TUMOR CELLS, CULTURED;

EID: 0030299911     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(96)00281-5     Document Type: Article

References (40)

1. 3. J Cell Biochem 56:303-306; 1994.
2. 3 and human bone-derived cells in vitro: Effects on alkaline phosphatase, type I collagen, and proliferation. Endocrinol 119:1176-1179; 1986.
3. 3. Bouillon, R., Okamura, W. H., and Norman, A. W. Structure-function relationships in the vitamin D endocrine system. Endocrine Rev 16:200-257; 1995.
4. 3 receptors in cultured rat osteoblast-like cells: glucorticoid treatment increases receptor content. J Biol Chem 258:4350-4355; 1983.
5. 3 receptors in cultured mouse bone cells. Correlation of receptor concentration with rate of cell division. J Biol Chem 256:5561-5566; 1981.
6. 3 in cultured mouse osteoblast-like cells. Modulation by changes in receptor level. J Cell Physiol 126:21-28; 1986.
7. 3 modulate the synthesis of insulin-like growth factor-I in osteoblast-like cells. Calcif Tiss Int 48:278-282; 1991.
8. 3. Mol Endocrinol 9:1814-1824; 1995.
9. 3 receptors. Cancer Res 44:2103-2109; 1984.
10. 3. News Physiol Sci 10:198-204; 1995.
11. 3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Endocrinology 129:1876-1884; 1991.
12. 3H]-thymidine incorporation and alkaline phosphatase activity in human osteoblast-like cells. Calcif Tiss Int 48:297-301; 1991.
13. 3. J Biol Chem 269:2971-2981; 1994.
14. 3 in human osteosarcoma cells. J Biol Chem 263:18938-18945; 1988.
15. 3 effects on alkaline phosphatase activity and parathyroid hormone responsiveness in an osteoblast-like osteosarcoma cell line. Endocrinology 119:932-939; 1986.
16. 3 inhibits transcription of type I collagen genes in the rat osteosarcoma cell line ROS 17/2.8. Endocrinology 125:327-333; 1989.
17. 3 hormone: Expression of the human vitamin D receptor in E. coli. J Steroid Biochem Mol Biol 53:583-594; 1995.
18. 3 on the proliferation of osteoblastic MC3T3-E1 cells by modulating the release of local regulators from monocytes. Biochem Biophys Res Comm 190:529-535; 1993.
19. 3 in osteosarcoma cells is independent of calcium influx. Endocrinology 135:2446-2453; 1994.
20. 20. Lajeunesse, D. Effect of 17-β estradiol on the human osteosarcoma cell line MG-63. Bone Miner 24:1-16; 1994.
21. 21. Lian, J. B. and Stein, G. S. Vitarain D regulation of osteoblast growth and differentiation. In: Berdanier, C. D. and Hargrove, I. L., Eds. Nutrition and Gene Expression. Baton Roca: CRCP; 1993; 391-429.
22. 22. Liel, Y., Kraus, S., Levy, J., and Shany, S. Evidence that estrogens modulate activity and increase the number of 1,25-dihydroxyvitamin D receptors in osteoblast-like cells (ROS 17/2.8). Endocrinology 130:2597-2601; 1992.
23. 23. Lowry, O. H. Micromethods for the assay of enzyme. II. Specific procedures: alkaline phosphatase. Methods Enzymol 4:371-372; 1955.
24. 3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells. Biochim Biophys Acta 1048:30-37; 1990.
25. 3. Differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res 50:6857-6864; 1990.
26. 3 receptor in rat osteosarcoma cells. J Biol Chem 262:4670-4676; 1987.
27. 27. Raisz, L. G. Local and systemic factors in the pathogenesis of osteoporosis. New Eng J Med 318:818-828; 1988.
28. 28. Rao, L. G., Wylie, J. N., Kung Sutherland, M. S., and Murray, T. M. 17-β estradiol and parathyroid hormone potentiate each other's stimulatory effects on alkaline phosphatase activity in SaOS-2 cells in a differentiation-dependent manner. Endocrinology 134:614-620; 1994.
29. 3 on alkaline phosphatase activity in human osteosarcoma cells in a differentiation-dependent manner. J Endocrinol 148:181-187; 1996.
30. 30. Ross, T. K., Darwish, H. M., and DeLuca, H. F. Molecular biology of vitamin D action. Vit Horm 49:281-326; 1994.
31. 31. Salomon, Y. Adenylate cyclase assay. Adv Cycl Nucl Res 10:35-55; 1979.
32. 3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129:3139-3146; 1991.
33. 33. Shen, V., Dempster, D. W., Birchman, R., Xu, R., and Lindsay, R. Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91:2479-2487; 1993.
34. 34. Shimizu, H., Daley, J. W., and Creveling, C. E. A radioisotopic method for measuring the formation of adenosine 3′5′-cyclic monophosphate in incubated slices of brain. J Neurochem 16:1609-1619; 1969.
35. 3 into their respective lactones. Endocrinology 136:4195-4203; 1995.
36. 3 on alkaline phosphatase and bone GLA-protein of rat osteoblastic cells. Endocrinology 118:1340-1346; 1986.
37. 3-analogs on osteoblast-like cells and on in vitro bone resorption. J Steroid Biochem Mol Biol 55:337-346; 1995.
38. 3. J Nutr 125:1690S-1694S; 1995.
39. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 78:75-82; 1991.
40. 40. Zhou, J.-Y., Norman, A. W., Lubbert, N. M., Collins, E., Uskokovic, M. R., and Koeffler, H. P. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization. Blood 74:82-93; 1989.